| 1 |
32496149 | Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors. | 2021 Apr |
2 |
| 2 |
30320358 | Hypoxia increases chemoresistance in human medulloblastoma DAOY cells via hypoxia‑inducible factor 1α‑mediated downregulation of the CYP2B6, CYP3A4 and CYP3A5 enzymes and inhibition of cell proliferation. | 2019 Jan |
1 |
| 3 |
30500380 | Metabolic activity testing can underestimate acute drug cytotoxicity as revealed by HepG2 cell clones overexpressing cytochrome P450 2C19 and 3A4. | 2019 Jan 15 |
3 |
| 4 |
27206429 | Monocrotophos Induces the Expression of Xenobiotic Metabolizing Cytochrome P450s (CYP2C8 and CYP3A4) and Neurotoxicity in Human Brain Cells. | 2017 Jul |
3 |
| 5 |
28976264 | Epistatic interactions among CYP2C19*2, CYP3A4 and GSTP1 on the cyclophosphamide therapy in lupus nephritis patients. | 2017 Oct |
3 |
| 6 |
25860621 | Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes. | 2015 May 18 |
1 |
| 7 |
24768782 | Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy. | 2014 Jul 1 |
1 |
| 8 |
22245954 | The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients. | 2012 May |
1 |
| 9 |
21487929 | The role of constitutive androstane receptor in oxazaphosphorine-mediated induction of drug-metabolizing enzymes in human hepatocytes. | 2011 Aug |
1 |
| 10 |
20040700 | Raltegravir-based HAART regimen in a patient with large B-cell lymphoma. | 2010 Feb |
1 |
| 11 |
18496131 | Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide. | 2008 Jun |
1 |
| 12 |
16595573 | Hepatic veno-occlusive disease associated with immunosuppressive cyclophosphamide dosing and roxithromycin. | 2006 Apr |
1 |
| 13 |
17164692 | Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin. | 2006 Dec |
2 |
| 14 |
15656694 | Interactions between antiretrovirals and antineoplastic drug therapy. | 2005 |
1 |
| 15 |
15919850 | Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450. | 2005 Sep |
2 |
| 16 |
16087946 | Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer. | 2005 Sep 1 |
2 |
| 17 |
12065440 | The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes. | 2002 Jul |
10 |
| 18 |
11770832 | Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. | 2001 Dec |
1 |
| 19 |
10692561 | Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. | 2000 Apr 15 |
4 |
| 20 |
10322772 | [Establishment of transgenic cell line CHL-3A4 and its metabolic activation]. | 1998 Sep |
1 |
| 21 |
9157990 | Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. | 1997 May 15 |
3 |
| 22 |
9331082 | Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes. | 1997 Oct 1 |
1 |
| 23 |
8242617 | Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. | 1993 Dec 1 |
1 |